275
Middlefield Road
Suite 200
Menlo
Park,
CA
94025
Tel:
650.327.2085
Fax:
650.327.1506
Email:
info@cedarecon.com
|
About Us
Our
vision is to provide life sciences organizations and companies with
scientifically reliable and credible evidence on clinical outcomes and
economics of services and technologies. We use state-of-the-art
analytical techniques and seek to present our findings in a manner that
is readily understood by a diverse audience, such as physicians,
patients, managers, and third-party payers and decision-makers.
We
provide:
- strategic
advice on design of clinical and commercial development programs, and
on design of clinical studies
- statistical
and econometric analyses concerning clinical effectiveness, treatment
patterns, costs of care, and quality of life
- decision
analyses that forecast the long-term real and potential implication of
novel healthcare products and services, such as cost-effectiveness
analyses and financial or budget impact analyses
- systematic
and
evidenced-based reviews of published literature pertaining to
epidemiology, burden of illness, treatment patterns, costs, and
clinical effectiveness of treatments
- communication
services for presenting analytical findings, including presentations at
international congresses, manuscripts in peer-reviewed journals, and
web-based and CD-ROM based interactive programs
We
have
close collaborations with numerous international renowned experts at
local, regional and national institutions (e.g,. Stanford, UC Berkeley,
California State University – East Bay, Sutter Health,
Veterans’ Affairs). These collaborations not only expand the
scope of state-of-the-art expertise on projects, but increases capacity
to readily staff projects.
Staff members include MS and PhD level analysts in statistics,
epidemiology, and economics, with almost all trained at Stanford
University and UC Berkeley. Cedar also has strategic partnerships with
other groups who have specialized data; these synergies help support
and maximize our research capabilities. Detailed descriptions of
resources, including biosketches of key personnel, are included in a
response to a proposal.
Cedar has much experience responding to a variety of proposals: small
companies (e.g., start ups), large pharmaceuticals, diagnostic and
device companies, and submissions of RO1 (investigator-initiated)
proposals to the NIH and other federal agencies. Some projects might
only require the development of a data analysis plan, with the
client’s own staff executing the programming. In other
projects, Cedar’s own data resources are utilized and the
analysis planning and programming are conducted entirely in-house. Our
structure and processes offer unprecedented and substantial flexibility
in putting together a top-notch project team focused on meeting the
client’s needs. Furthermore, all of our key personnel have
long-standing professional connections with counterparts in key
decision-making and policy positions at the FDA, NIH, CMS, and various
MCOs. They can attest to the credibility of our work.
Cedar Associates LLC is not is one of the many large “data
shops” where the work is relegated to less experienced staff
at premium prices. We work on projects with clients who are intent on
making a difference and whose interests and goals align with ours. We
do not actively advertise, as much of our business has been
successfully garnered from personal referrals (word of mouth) by
existing clients.
If our capabilities may be of use to your company, please feel free to
contact us to see if we can meet your needs.
|
